Write My Paper Button

WhatsApp Widget

NUR6150 Advanced Practice in Primary Care: Pediatrics

NUR6150 Advanced Practice in Primary Care: Pediatrics

Signature Assignment

Understanding disease conditions specific to pediatrics is vital to ensure proper and diagnosis and treatment to improve healthcare outcomes for the patient. The purpose of this assignment is to evaluate one disease condition in the pediatric population and explore current evidence-based guidelines and treatments to determine a proper plan of care.

This assignment will focus on the following course student learning outcomes (CSLO):

2. Develop advanced prac/ce care plans to help manage the delivery of health care to the pediatric client and family (EOPSLO# 3, 5, 6, 7). 3. U/lize relevant evidence-based research findings in the clinical management of the pediatric client (EOPSLO# 1, 3, 4). 4. Integrate legal, ethical, socioeconomic, psychosocial, and cultural factors in the delivery of health care to the pediatric client (EOPSLO# 2, 6). 6. Communicate prac/ce knowledge effec/vely both orally and in wri/ng (EOPSLO# 5). 7. Demonstrates informa/on literacy skills in complex decision-making (EOPSLO# 1, 5).

Instruc+ons: Please choose one pediatric health condition learned in the course. Once the health condi/on is chosen, you are to write a three-to-five-page paper in APA format 7th edi/on with the following sec/ons and level 2 headings:

Introduction

-Brief overview of pediatric health

-Introduce the disease condition/on the chosen

-Importance of understanding the conditions/on

 

-Describe the condition chosen and its pathophysiology.

-What signs/symptoms are iden/fied in the pa/ent that can be found?

-Iden/fy if there can be presenta/on varia/ons based on culture, race, ethnicity, age, etc.

Diagnosis of Condi@on

-Diagnos/c tes/ng (include imaging, labs, and other necessary evaluate/ons based on condition)

SCHOOL OF NURSING GRADUATE STUDIES

MASTER OF SCIENCE IN NURSING – FNP

-Clinical evaluation via medical history and physical examination/on

Treatment of Condition

-Medica/ons

-Treatments

-Managing symptoms (if needed)

-Non-pharmacological treatments (if applicable)

Potential Health Risks if Leo Untreated

-Physical and mental health risks

Recent Evidence-Based Advancements in Condition

-Choose one evidence-based treatment that has been shown to improve the condition within the last 5 years.

-Briefly summarize the treatment and results.

Conclusion

-Recap points discussed in the paper

-Importance of management and early diagnosis (if applicable)

NUR6150 Advanced Practice in Primary Care: Pediatrics

 

ORDER A PLAGIARISM-FREE PAPER HERE

An Original Human-Crafted Assignment

**Pediatric Asthma: Understanding the Disease and Evidence-Based Management**

 

**Introduction**

 

Pediatric health encompasses a diverse array of conditions that require specialized care and attention. Among these conditions, pediatric asthma stands out as one of the most prevalent chronic respiratory diseases affecting children worldwide. This paper aims to provide a comprehensive overview of pediatric asthma, including its pathophysiology, diagnosis, treatment options, potential health risks, and recent evidence-based advancements in management.

 

**Overview of Pediatric Health and Importance of Understanding Pediatric Conditions**

 

Pediatric health encompasses the physical, mental, and social well-being of children from infancy through adolescence. It is crucial to understand pediatric conditions to ensure optimal health outcomes for this vulnerable population. Pediatric asthma is a chronic inflammatory disorder of the airways characterized by recurring episodes of wheezing, breathlessness, chest tightness, and coughing, particularly at night or early in the morning.

 

**Pathophysiology of Pediatric Asthma**

 

The pathophysiology of pediatric asthma involves complex interactions between genetic predisposition, environmental factors, and immune responses. In susceptible individuals, exposure to triggers such as allergens, respiratory infections, irritants, and exercise can lead to airway inflammation, bronchoconstriction, and increased mucus production. This inflammatory response narrows the airways, causing symptoms characteristic of asthma exacerbations.

 

**Diagnosis of Pediatric Asthma**

 

Diagnosis of pediatric asthma involves a comprehensive evaluation of the patient’s medical history, physical examination, and diagnostic testing. Clinical evaluation may reveal symptoms such as wheezing, coughing, dyspnea, and chest tightness. Diagnostic tests commonly used to confirm asthma diagnosis include pulmonary function tests (spirometry), peak expiratory flow rate measurement, and bronchial provocation tests. Additionally, imaging studies such as chest X-rays may be performed to rule out other respiratory conditions.

 

**Treatment of Pediatric Asthma**

 

Treatment of pediatric asthma aims to achieve and maintain asthma control, reduce symptoms, minimize exacerbations, and improve the quality of life for children with asthma. Pharmacological interventions include long-term control medications (e.g., inhaled corticosteroids, leukotriene receptor antagonists) to reduce airway inflammation and quick-relief medications (e.g., short-acting beta-agonists) to relieve acute symptoms. Non-pharmacological treatments such as allergen avoidance, smoking cessation, and asthma education are also essential components of asthma management.

 

**Potential Health Risks if Left Untreated**

 

Untreated pediatric asthma can lead to various physical and mental health risks, including impaired lung function, decreased physical activity, frequent school absenteeism, poor sleep quality, and decreased quality of life. Furthermore, uncontrolled asthma exacerbations may result in respiratory failure, hospitalization, and even death in severe cases.

 

**Recent Evidence-Based Advancements in Pediatric Asthma Management**

 

Recent evidence-based advancements in pediatric asthma management include the introduction of biologic therapies targeting specific inflammatory pathways implicated in asthma pathogenesis. For example, monoclonal antibodies targeting immunoglobulin E (IgE) or interleukin-5 (IL-5) have shown efficacy in reducing exacerbations and improving asthma control in children with severe allergic or eosinophilic asthma.

 

**Conclusion**

 

In conclusion, pediatric asthma is a common chronic respiratory condition characterized by airway inflammation and bronchoconstriction. Early diagnosis, appropriate treatment, and ongoing management are essential to achieving optimal health outcomes for children with asthma. Recent evidence-based advancements, such as biologic therapies, offer promising options for improving asthma control and reducing the burden of disease in pediatric patients.

 

References:

 

National Asthma Education and Prevention Program. (2007). Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. National Heart, Lung, and Blood Institute.

 

Global Initiative for Asthma. (2021). Global Strategy for Asthma Management and Prevention. Retrieved from https://ginasthma.org/.

 

Teach, S. J., & Gergen, P. J. (2016). Risk factors for pediatric asthma. Journal of Allergy and Clinical Immunology, 138(3), 691-699. doi:10.1016/j.jaci.2016.07.006.

NUR6150 Advanced Practice in Primary Care: Pediatrics

 

The post NUR6150 Advanced Practice in Primary Care: Pediatrics appeared first on Destiny Papers.

NUR6150 Advanced Practice in Primary Care: Pediatrics
Scroll to top

Submit Your Instructions to Writers for FREE!!

This is default text for notification bar